If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Kropz gets more cash; Audioboom releases new podcasts

Thu, 01st Sep 2022 21:55

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Open Orphan PLC - London-based pharmaceutical services - Its clinical laboratories in Queen Mary's Bioenterprise Centre and Plumbers Row wins accreditation by the College of American Pathologists. "The company sought the accreditation as part of its ongoing commitment to maintaining best in class quality systems," it explains.

----------

Audioboom Group PLC - London-based podcast producer - Expands its podcast network with the launch of three new shows from Audioboom Studios, the company's production arm. "Audioboom's continued investment into content development will further grow the company's intellectual property, deliver increased gross margins to the business, expand audience reach, and develop premium advertising inventory," it says. Launches 'Glittering A Turd' from Kris Hallenga, 'Killers, Cults and Queens' from Cheryl Hole and Nikki Druce, and 'Superpower State of Mind' from Malin Andersson.

----------

Sopheon PLC - Minnesota, US-based enterprise software provider - Updates management product Accolade. "Using Accolade, Sopheon's long-standing blue-chip customers across a diverse range of industries have experienced superior strategy-to-execution performance, reduced time-to-market, improved efficiency, and greater product success rate," it explains.

----------

Cloudbreak Discovery PLC - Vancouver, Canada-based natural resource project generator - Draws down GBP180,000 of the GBP10 million equity drawdown agreement with Crescita Capital LLC, which was originally entered into in February 2021. Shares issued at 1.5 pence each, seeing 12 million new shares issued. "The capital drawn down will be used to advance the company's acquisitions of energy royalties, lithium assets and bauxite projects globally," it explains.

----------

Power Metal Resources PLC - metals exploration company focused on North America, Africa and Australia - Wholly owned Australian subsidiary Power Metal Resources Australia sees confirmation of grant of exploration licence application 2021-000163, covering 999 square kilometres of ground in the Anna Creek area of South Australia. Exploration licence will last for 6 years, ending August 2028, and subject to minimum spend of AUD100,000, about GBP59,000. Chief Executive Paul Johnson says: "There is more work to do, clearly, and we are early stage here, however all projects of substance start early stage and the Wilan Project is off to a great start."

----------

Kropz PLC - African phosphate developer - Draws down ZAR47 million from recent bridge loan facility of ZAR121.5 million with major shareholder, the ARC Fund, to meet immediate cash requirements due to further delays in the ramp up of operations at Kropz Elandsfontein Ltd. "Progress continues to be made, however, in the ramp up," it adds. "Kropz and ARC Fund are currently working on a comprehensive funding structure to finance any further funding requirements in Kropz."

----------

Hummingbird Resources PLC - gold production, development and exploration focused on West Africa - Says development and construction of its second gold mine, Kouroussa, is now over 50% completed and remains on time and budget to achieve first gold pour by the end of the second quarter of 2023, which will more than double Hummingbird's gold production profile. Notes final assay results confirmed, with results showing 9.0 metres at 32.60 grammes per tonne gold from 116 metres.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
9 Jul 2021 11:42

Open Orphan inks contract with AIM ImmunoTech to test Ampligen drug

Open Orphan inks contract with AIM ImmunoTech to test Ampligen drug

Read more
9 Jul 2021 10:52

AIM WINNERS & LOSERS: Evgen disappointed as SFX-01 flops study hurdle

AIM WINNERS & LOSERS: Evgen disappointed as SFX-01 flops study hurdle

Read more
9 Jul 2021 10:20

Open Orphan subsidiary scores 'significant contract' with AIM ImmunoTech

(Sharecast News) - Clinical research organisation Open Orphan's hVIVO subsidiary has signed "a significant contract" to test AIM ImmunoTech's antiviral candidate, Ampligen.

Read more
17 Jun 2021 14:34

Cathal Friel-led Poolbeg Pharma set to float on AIM

(Sharecast News) - Infectious disease specialist Poolbeg Pharma is to list on the London Stock Exchange's junior market, AIM, with a view to raising the funds needed to develop its product pipeline.

Read more
17 Jun 2021 14:05

Open Orphan reports widened 2020 loss; Poolbeg mulls London float

Open Orphan reports widened 2020 loss; Poolbeg mulls London float

Read more
17 Jun 2021 11:43

AIM WINNERS & LOSERS: Midatech Pharma up 90% on Q-Sphera breakthrough

AIM WINNERS & LOSERS: Midatech Pharma up 90% on Q-Sphera breakthrough

Read more
16 Jun 2021 16:00

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
19 May 2021 19:33

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

Read more
10 May 2021 13:37

TRADING UPDATES: Begbies buys finance broker; Amino Tech makes US bid

TRADING UPDATES: Begbies buys finance broker; Amino Tech makes US bid

Read more
10 May 2021 09:30

Open Orphan subsidiary signs contract to make Covid-19 challenge virus

(Sharecast News) - Specialist pharmaceutical services contract research organisation Open Orphan announced on Monday that its subsidiary hVIVO has signed a contract with Imperial College London, as part of a Wellcome Trust-funded initiative to manufacture a SARS-CoV-2 challenge virus.

Read more
6 May 2021 15:33

EXECUTIVE CHANGES: New Cenkos CEO gets FCA nod; Feedback hires CFO

EXECUTIVE CHANGES: New Cenkos CEO gets FCA nod; Feedback hires CFO

Read more
9 Apr 2021 10:33

Open Orphan launches new data platform to combat infectious diseases

Open Orphan launches new data platform to combat infectious diseases

Read more
26 Mar 2021 14:36

TRADING UPDATES: Renew to buy J Browne; Idox in good start to year

TRADING UPDATES: Renew to buy J Browne; Idox in good start to year

Read more
25 Mar 2021 17:14

TRADING UPDATES: SpaceandPeople swings to loss in 2020 amid virus

TRADING UPDATES: SpaceandPeople swings to loss in 2020 amid virus

Read more
25 Mar 2021 15:34

Open Orphan makes progress with Covid-19 characterisation study

(Sharecast News) - Specialist pharmaceutical services clinical research company Open Orphan updated the market on its world-first Covid-19 characterisation study on Thursday, reporting that the first three volunteers had now completed the quarantine phase.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.